Oscar Health, Inc. (NYSE: OSCR) Stock Competitors & Peer Comparison
See OSCR's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Plans Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for OSCR and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| OSCR | $29.91 | +6.94% | 7.7B | 21.15 | $1.40 | N/A |
| UNH | $401.92 | -0.07% | 368.4B | 24.82 | $16.34 | +2.21% |
| CVS | $95.17 | -0.52% | 119.3B | 11.93 | $7.84 | +2.81% |
| ANTM | $482.58 | +2.71% | 114.6B | 18.99 | $25.41 | +1.42% |
| ELV | $400.23 | +2.53% | 86.6B | 13.58 | $29.39 | +1.73% |
| CI | $277.86 | +1.46% | 73.3B | 8.98 | $30.90 | +2.21% |
| HUM | $385.12 | +3.30% | 46.7B | 24.51 | $15.86 | +0.92% |
| CNC | $66.52 | -0.08% | 32B | 25.74 | $2.52 | N/A |
| MOH | $207.08 | +6.45% | 10.8B | 29.78 | $6.92 | N/A |
| ALHC | $13.63 | +3.22% | 2.8B | 150.22 | $0.09 | N/A |
Stock Comparison
UnitedHealth Group Incorporated (NYSE: UNH)
OSCR vs UNH Comparison August 2026
Oscar Health, Inc. (NYSE: OSCR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSCR stands at 7.7B. In comparison, UNH has a market cap of 368.4B. Regarding current trading prices, OSCR is priced at $29.91 on the NYSE, while UNH trades at $401.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSCR currently has a P/E ratio of 21.15, whereas UNH's P/E ratio is 24.82. In terms of profitability, OSCR's ROE is +0.39%, compared to UNH's ROE of +0.14%. Regarding short-term risk, OSCR is more volatile compared to UNH. This indicates higher risk in terms of short-term price fluctuations for OSCR.Check UNH's competition here
CVS Health Corp. (NYSE: CVS)
OSCR vs CVS Comparison August 2026
Oscar Health, Inc. (NYSE: OSCR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSCR stands at 7.7B. In comparison, CVS has a market cap of 119.3B. Regarding current trading prices, OSCR is priced at $29.91 on the NYSE, while CVS trades at $95.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSCR currently has a P/E ratio of 21.15, whereas CVS's P/E ratio is 11.93. In terms of profitability, OSCR's ROE is +0.39%, compared to CVS's ROE of +0.06%. Regarding short-term risk, OSCR is more volatile compared to CVS. This indicates higher risk in terms of short-term price fluctuations for OSCR.Check CVS's competition here
Elevance Health Inc. (NYSE: ANTM)
OSCR vs ANTM Comparison August 2026
Oscar Health, Inc. (NYSE: OSCR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSCR stands at 7.7B. In comparison, ANTM has a market cap of 114.6B. Regarding current trading prices, OSCR is priced at $29.91 on the NYSE, while ANTM trades at $482.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSCR currently has a P/E ratio of 21.15, whereas ANTM's P/E ratio is 18.99. In terms of profitability, OSCR's ROE is +0.39%, compared to ANTM's ROE of +0.11%. Regarding short-term risk, OSCR is less volatile compared to ANTM. This indicates lower risk in terms of short-term price fluctuations for OSCR.Check ANTM's competition here
Elevance Health Inc. (NYSE: ELV)
OSCR vs ELV Comparison August 2026
Oscar Health, Inc. (NYSE: OSCR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSCR stands at 7.7B. In comparison, ELV has a market cap of 86.6B. Regarding current trading prices, OSCR is priced at $29.91 on the NYSE, while ELV trades at $400.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSCR currently has a P/E ratio of 21.15, whereas ELV's P/E ratio is 13.58. In terms of profitability, OSCR's ROE is +0.39%, compared to ELV's ROE of +0.11%. Regarding short-term risk, OSCR is more volatile compared to ELV. This indicates higher risk in terms of short-term price fluctuations for OSCR.Check ELV's competition here
Cigna Corporation (NYSE: CI)
OSCR vs CI Comparison August 2026
Oscar Health, Inc. (NYSE: OSCR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSCR stands at 7.7B. In comparison, CI has a market cap of 73.3B. Regarding current trading prices, OSCR is priced at $29.91 on the NYSE, while CI trades at $277.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSCR currently has a P/E ratio of 21.15, whereas CI's P/E ratio is 8.98. In terms of profitability, OSCR's ROE is +0.39%, compared to CI's ROE of +0.15%. Regarding short-term risk, OSCR is more volatile compared to CI. This indicates higher risk in terms of short-term price fluctuations for OSCR.Check CI's competition here
Humana Inc. (NYSE: HUM)
OSCR vs HUM Comparison August 2026
Oscar Health, Inc. (NYSE: OSCR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSCR stands at 7.7B. In comparison, HUM has a market cap of 46.7B. Regarding current trading prices, OSCR is priced at $29.91 on the NYSE, while HUM trades at $385.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSCR currently has a P/E ratio of 21.15, whereas HUM's P/E ratio is 24.51. In terms of profitability, OSCR's ROE is +0.39%, compared to HUM's ROE of +0.07%. Regarding short-term risk, OSCR is more volatile compared to HUM. This indicates higher risk in terms of short-term price fluctuations for OSCR.Check HUM's competition here
Centene Corp. (NYSE: CNC)
OSCR vs CNC Comparison August 2026
Oscar Health, Inc. (NYSE: OSCR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSCR stands at 7.7B. In comparison, CNC has a market cap of 32B. Regarding current trading prices, OSCR is priced at $29.91 on the NYSE, while CNC trades at $66.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSCR currently has a P/E ratio of 21.15, whereas CNC's P/E ratio is 25.74. In terms of profitability, OSCR's ROE is +0.39%, compared to CNC's ROE of -0.24%. Regarding short-term risk, OSCR is more volatile compared to CNC. This indicates higher risk in terms of short-term price fluctuations for OSCR.Check CNC's competition here
Molina Healthcare, Inc. (NYSE: MOH)
OSCR vs MOH Comparison August 2026
Oscar Health, Inc. (NYSE: OSCR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSCR stands at 7.7B. In comparison, MOH has a market cap of 10.8B. Regarding current trading prices, OSCR is priced at $29.91 on the NYSE, while MOH trades at $207.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSCR currently has a P/E ratio of 21.15, whereas MOH's P/E ratio is 29.78. In terms of profitability, OSCR's ROE is +0.39%, compared to MOH's ROE of -0.00%. Regarding short-term risk, OSCR is more volatile compared to MOH. This indicates higher risk in terms of short-term price fluctuations for OSCR.Check MOH's competition here
Alignment Healthcare, Inc. (NASDAQ: ALHC)
OSCR vs ALHC Comparison August 2026
Oscar Health, Inc. (NYSE: OSCR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSCR stands at 7.7B. In comparison, ALHC has a market cap of 2.8B. Regarding current trading prices, OSCR is priced at $29.91 on the NYSE, while ALHC trades at $13.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSCR currently has a P/E ratio of 21.15, whereas ALHC's P/E ratio is 150.22. In terms of profitability, OSCR's ROE is +0.39%, compared to ALHC's ROE of +0.20%. Regarding short-term risk, OSCR is more volatile compared to ALHC. This indicates higher risk in terms of short-term price fluctuations for OSCR.Check ALHC's competition here
Clover Health Investments, Corp. (NASDAQ: CLOV)
OSCR vs CLOV Comparison August 2026
Oscar Health, Inc. (NYSE: OSCR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSCR stands at 7.7B. In comparison, CLOV has a market cap of 2.3B. Regarding current trading prices, OSCR is priced at $29.91 on the NYSE, while CLOV trades at $4.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSCR currently has a P/E ratio of 21.15, whereas CLOV's P/E ratio is 102.95. In terms of profitability, OSCR's ROE is +0.39%, compared to CLOV's ROE of -0.05%. Regarding short-term risk, OSCR is less volatile compared to CLOV. This indicates lower risk in terms of short-term price fluctuations for OSCR.Check CLOV's competition here
Bright Health Group, Inc. (NYSE: BHG)
OSCR vs BHG Comparison August 2026
Oscar Health, Inc. (NYSE: OSCR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSCR stands at 7.7B. In comparison, BHG has a market cap of 130.5M. Regarding current trading prices, OSCR is priced at $29.91 on the NYSE, while BHG trades at $16.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSCR currently has a P/E ratio of 21.15, whereas BHG's P/E ratio is -0.12. In terms of profitability, OSCR's ROE is +0.39%, compared to BHG's ROE of +0.04%. Regarding short-term risk, OSCR is less volatile compared to BHG. This indicates lower risk in terms of short-term price fluctuations for OSCR.Check BHG's competition here
Caring Brands, Inc. (NASDAQ: CABR)
OSCR vs CABR Comparison August 2026
Oscar Health, Inc. (NYSE: OSCR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSCR stands at 7.7B. In comparison, CABR has a market cap of 12.6M. Regarding current trading prices, OSCR is priced at $29.91 on the NYSE, while CABR trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSCR currently has a P/E ratio of 21.15, whereas CABR's P/E ratio is -2.48. In terms of profitability, OSCR's ROE is +0.39%, compared to CABR's ROE of -3.28%. Regarding short-term risk, OSCR is less volatile compared to CABR. This indicates lower risk in terms of short-term price fluctuations for OSCR.Check CABR's competition here
Universal American Corporation (NYSE: UAM)
OSCR vs UAM Comparison August 2026
Oscar Health, Inc. (NYSE: OSCR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSCR stands at 7.7B. In comparison, UAM has a market cap of 0. Regarding current trading prices, OSCR is priced at $29.91 on the NYSE, while UAM trades at $1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSCR currently has a P/E ratio of 21.15, whereas UAM's P/E ratio is 1.01. In terms of profitability, OSCR's ROE is +0.39%, compared to UAM's ROE of +0.17%. Regarding short-term risk, OSCR is more volatile compared to UAM. This indicates higher risk in terms of short-term price fluctuations for OSCR.Check UAM's competition here
Aetna Inc. (NYSE: AET)
OSCR vs AET Comparison August 2026
Oscar Health, Inc. (NYSE: OSCR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSCR stands at 7.7B. In comparison, AET has a market cap of 0. Regarding current trading prices, OSCR is priced at $29.91 on the NYSE, while AET trades at $106.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSCR currently has a P/E ratio of 21.15, whereas AET's P/E ratio is 9.57. In terms of profitability, OSCR's ROE is +0.39%, compared to AET's ROE of +0.11%. Regarding short-term risk, OSCR is more volatile compared to AET. This indicates higher risk in terms of short-term price fluctuations for OSCR.Check AET's competition here
Magellan Health, Inc. (NASDAQ: MGLN)
OSCR vs MGLN Comparison August 2026
Oscar Health, Inc. (NYSE: OSCR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSCR stands at 7.7B. In comparison, MGLN has a market cap of 0. Regarding current trading prices, OSCR is priced at $29.91 on the NYSE, while MGLN trades at $94.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSCR currently has a P/E ratio of 21.15, whereas MGLN's P/E ratio is 8.49. In terms of profitability, OSCR's ROE is +0.39%, compared to MGLN's ROE of +0.00%. Regarding short-term risk, OSCR is more volatile compared to MGLN. This indicates higher risk in terms of short-term price fluctuations for OSCR.Check MGLN's competition here
Triple-S Management Corporation (NYSE: GTS)
OSCR vs GTS Comparison August 2026
Oscar Health, Inc. (NYSE: OSCR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OSCR stands at 7.7B. In comparison, GTS has a market cap of 0. Regarding current trading prices, OSCR is priced at $29.91 on the NYSE, while GTS trades at $35.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OSCR currently has a P/E ratio of 21.15, whereas GTS's P/E ratio is 10.41. In terms of profitability, OSCR's ROE is +0.39%, compared to GTS's ROE of +0.07%. Regarding short-term risk, OSCR is more volatile compared to GTS. This indicates higher risk in terms of short-term price fluctuations for OSCR.Check GTS's competition here